Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

EBF4 Inhibitors

EBF4 inhibitors are a class of chemical compounds specifically designed to target and inhibit the activity of the EBF4 protein, a member of the EBF (Early B-cell Factor) family of transcription factors. The EBF family is known for its critical role in the regulation of gene expression, particularly in processes related to cellular differentiation and development. While the exact function of EBF4 is not as well-characterized as other members of the EBF family, it is believed to play a significant role in the regulation of gene expression during early developmental stages, potentially influencing the differentiation of specific cell types and the maintenance of cellular identity. EBF4 is likely involved in binding to specific DNA sequences to regulate the transcription of genes essential for these processes. The inhibition of EBF4 by specific inhibitors typically involves the binding of these compounds to functional domains of the EBF4 protein, such as the DNA-binding domain or regions responsible for protein-protein interactions. This binding prevents EBF4 from binding to its target DNA sequences or interacting with other transcriptional regulators, thereby disrupting its ability to regulate gene expression. Inhibiting EBF4 can lead to significant downstream effects, such as alterations in the transcriptional programs that govern cell fate decisions, differentiation, and developmental pathways. Additionally, EBF4 inhibitors might impact the stability and function of transcriptional complexes that include EBF4, potentially affecting broader networks of gene regulation within the cell. By studying the effects of EBF4 inhibition, researchers can gain valuable insights into the specific roles this transcription factor plays in cellular physiology, contributing to a deeper understanding of the molecular mechanisms that control gene expression during development and differentiation. This knowledge is crucial for unraveling the complex regulatory networks that maintain cellular identity and function across different stages of development.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Valproic Acid

99-66-1sc-213144
10 g
$87.00
9
(1)

Valproic acid, another histone deacetylase inhibitor, may influence the expression of genes like EBF4.

5-Aza-2′-Deoxycytidine

2353-33-5sc-202424
sc-202424A
sc-202424B
25 mg
100 mg
250 mg
$218.00
$322.00
$426.00
7
(1)

A DNA methyltransferase inhibitor that might change methylation patterns and influence EBF4 expression.

Etoposide (VP-16)

33419-42-0sc-3512B
sc-3512
sc-3512A
10 mg
100 mg
500 mg
$51.00
$231.00
$523.00
63
(1)

Etoposide inhibits topoisomerase II, potentially affecting DNA replication and transcription, which could impact EBF4 expression.

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$74.00
$243.00
$731.00
$2572.00
$21848.00
53
(3)

It binds to DNA and inhibits RNA polymerase, potentially decreasing transcription of the EBF4 gene.

DRB

53-85-0sc-200581
sc-200581A
sc-200581B
sc-200581C
10 mg
50 mg
100 mg
250 mg
$43.00
$189.00
$316.00
$663.00
6
(1)

DRB inhibits RNA polymerase II transcription elongation, potentially leading to reduced EBF4 expression.

α-Amanitin

23109-05-9sc-202440
sc-202440A
1 mg
5 mg
$269.00
$1050.00
26
(2)

α-Amanitin is an inhibitor of RNA polymerase II and could reduce the transcription of genes like EBF4.

Suberoylanilide Hydroxamic Acid

149647-78-9sc-220139
sc-220139A
100 mg
500 mg
$133.00
$275.00
37
(2)

Vorinostat is a histone deacetylase inhibitor that could affect gene expression patterns, including EBF4.

Puromycin dihydrochloride

58-58-2sc-108071
sc-108071B
sc-108071C
sc-108071A
25 mg
250 mg
1 g
50 mg
$42.00
$214.00
$832.00
$66.00
394
(16)

Puromycin causes premature termination of protein synthesis, potentially reducing levels of proteins like EBF4.

Cycloheximide

66-81-9sc-3508B
sc-3508
sc-3508A
100 mg
1 g
5 g
$41.00
$84.00
$275.00
127
(6)

Cycloheximide inhibits eukaryotic protein synthesis, which could reduce the overall production of EBF4.